Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-25-001193
Filing Date
2025-08-14
Accepted
2025-08-14 16:30:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6582
  Complete submission text file 0001193805-25-001193.txt   8262
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

EIN.: 651311552 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-87649 | Film No.: 251219889
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 590 MADISON AVENUE 23RD FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 23RD FLOOR NEW YORK NY 10022 212-832-0900
Schonfeld Strategic Advisors LLC (Filed by) CIK: 0001665241 (see all company filings)

EIN.: 475082310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A